ロード中...
5-ASA inhibits epithelial β-catenin activation in chronic ulcerative colitis
BACKGROUND & AIMS: 5-aminosalicylic acid (5-ASA) is a mainstay therapeutic agent in chronic ulcerative colitis (CUC) where it reverses crypt architectural changes and reduces colitis-associated cancer (CAC). The present study addressed the possibility that 5-ASA reduces β-catenin-associated prog...
保存先:
| 主要な著者: | , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2009
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2819654/ https://ncbi.nlm.nih.gov/pubmed/19879273 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.gastro.2009.10.038 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|